New
HealthMore in Health→
Blocking TET2 Could Help Radiation Treatments Fight Cancer
Key Takeaways
- Radiation can expand immune-suppressing MDSCs that inhibit tumor-killing CD8-positive T cells.
- In samples from 33 patients with advanced non-small cell lung cancer, TET2 rose after radiation most sharply in nonresponders.
- Blocking TET2 redirected radiation-activated immune cells toward anti-tumor activity in the reported experiments.
DE
DT Editorial Team··via medicalxpress.com